476 related articles for article (PubMed ID: 17398018)
21. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
[TBL] [Abstract][Full Text] [Related]
22. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L
Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256
[TBL] [Abstract][Full Text] [Related]
23. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
[TBL] [Abstract][Full Text] [Related]
24. FDG-PET-CT reduces the interobserver variability in rectal tumor delineation.
Buijsen J; van den Bogaard J; van der Weide H; Engelsman S; van Stiphout R; Janssen M; Beets G; Beets-Tan R; Lambin P; Lammering G
Radiother Oncol; 2012 Mar; 102(3):371-6. PubMed ID: 22280807
[TBL] [Abstract][Full Text] [Related]
25. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
[TBL] [Abstract][Full Text] [Related]
26. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
[TBL] [Abstract][Full Text] [Related]
27. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
Baek CH; Chung MK; Son YI; Choi JY; Kim HJ; Yim YJ; Ko YH; Choi J; Cho JK; Jeong HS
J Nucl Med; 2008 Sep; 49(9):1422-8. PubMed ID: 18703597
[TBL] [Abstract][Full Text] [Related]
28. Reproducibility of "intelligent" contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method.
Bayne M; Hicks RJ; Everitt S; Fimmell N; Ball D; Reynolds J; Lau E; Pitman A; Ware R; MacManus M
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1151-7. PubMed ID: 20610039
[TBL] [Abstract][Full Text] [Related]
29. PET and PET-CT in radiation treatment planning for lung cancer.
Aristei C; Falcinelli L; Palumbo B; Tarducci R
Expert Rev Anticancer Ther; 2010 Apr; 10(4):571-84. PubMed ID: 20397922
[TBL] [Abstract][Full Text] [Related]
30. Fluorine 18 fluorodeoxyglucose PET/CT volume-based indices in locally advanced non-small cell lung cancer: prediction of residual viable tumor after induction chemotherapy.
Soussan M; Cyrta J; Pouliquen C; Chouahnia K; Orlhac F; Martinod E; Eder V; Morère JF; Buvat I
Radiology; 2014 Sep; 272(3):875-84. PubMed ID: 24761836
[TBL] [Abstract][Full Text] [Related]
31. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
[TBL] [Abstract][Full Text] [Related]
32. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
Hong R; Halama J; Bova D; Sethi A; Emami B
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):720-6. PubMed ID: 17293230
[TBL] [Abstract][Full Text] [Related]
33. 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist?
Hanna GG; Carson KJ; Lynch T; McAleese J; Cosgrove VP; Eakin RL; Stewart DP; Zatari A; O'Sullivan JM; Hounsell AR
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1040-51. PubMed ID: 20350798
[TBL] [Abstract][Full Text] [Related]
34. Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation.
Castadot P; Geets X; Lee JA; Christian N; Grégoire V
Radiother Oncol; 2010 May; 95(2):209-17. PubMed ID: 20385413
[TBL] [Abstract][Full Text] [Related]
35. Comparison of PET-CT images with the histopathological picture of a resectable primary tumor for delineating GTV in nonsmall cell lung cancer.
Lin S; Han B; Yu L; Shan D; Wang R; Ning X
Nucl Med Commun; 2011 Jun; 32(6):479-85. PubMed ID: 21394047
[TBL] [Abstract][Full Text] [Related]
36. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.
Werner-Wasik M; Swann RS; Bradley J; Graham M; Emami B; Purdy J; Sause W
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):385-90. PubMed ID: 17869017
[TBL] [Abstract][Full Text] [Related]
37. Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study.
Bettinardi V; Mancosu P; Danna M; Giovacchini G; Landoni C; Picchio M; Gilardi MC; Savi A; Castiglioni I; Lecchi M; Fazio F
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):214-23. PubMed ID: 17464266
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.
Newbold KL; Partridge M; Cook G; Sharma B; Rhys-Evans P; Harrington KJ; Nutting CM
Acta Oncol; 2008; 47(7):1229-36. PubMed ID: 18661420
[TBL] [Abstract][Full Text] [Related]
39. Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients.
Takenaka D; Ohno Y; Koyama H; Nogami M; Onishi Y; Matsumoto K; Matsumoto S; Yoshikawa T; Sugimura K
Eur J Radiol; 2010 Jun; 74(3):458-64. PubMed ID: 19398291
[TBL] [Abstract][Full Text] [Related]
40. The impact of positron emission tomography/computed tomography in edge delineation of gross tumor volume for head and neck cancers.
Ashamalla H; Guirgius A; Bieniek E; Rafla S; Evola A; Goswami G; Oldroyd R; Mokhtar B; Parikh K
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):388-95. PubMed ID: 17324530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]